Over 80% of the world's population lives in low- and middle-income countries (LMICs), yet these regions account for less than 6% of global pharmaceutical revenue, leaving hundreds of millions without access to essential medicines. Axmed exists to change this reality. Through a technology-driven B2B marketplace, the company connects healthcare procurers directly with trusted pharmaceutical suppliers, eliminating the fragmented systems that keep medicines out of reach and creating a transparent, efficient procurement ecosystem.
As a social impact venture, Axmed operates with radical transparency - capping markups at 10% in an industry where 250% is commonplace and redeploying 30% of profits back into the health systems served. Since launching the platform, Axmed has reached 4.2 million patients, achieved 35% average cost savings on medicines, and built a network of 130+ active procurers and suppliers across 5,000 products. With headquarters in Switzerland and regional operations in Nairobi, the company combines cutting-edge technology with strategic partnerships to accelerate equitable access to medicines for the 6.5 billion people who need them most.
